Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for a brain stem glioma provide very limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of brain stem gliomas.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on children (> 6 months of age) and adults with newly-diagnosed or
recurrent brain stem gliomas.